Jump Financial, LLC Dyne Therapeutics, Inc. Transaction History

Jump Financial, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$13.06 - $29.18 $357,608 - $799,006	27,382 New	27,382 $777,000
Q1 2023 Oct 21, 2024	BUY	$10.88 - $15.0 $261,816 - $360,960	24,064 New	24,064 $277,000
Q1 2023 May 03, 2023	SELL	$10.88 - $15.0 $101,086 - $139,365	-9,291 Reduced 27.85%	24,064 $277,000
Q4 2022 Feb 13, 2023	BUY	$9.37 - $13.8 $29,674 - $43,704	3,167 Added 10.49%	33,355 $386,000
Q3 2022 Nov 07, 2022	BUY	$7.2 - $15.17 $217,353 - $457,951	30,188 New	30,188 $383,000
Q1 2022 May 12, 2022	SELL	$6.52 - $12.27 $124,531 - $234,357	-19,100 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$11.89 - $16.07 $227,099 - $306,937	19,100 New	19,100 $227,000

210

102M

234K

238K

Ticker DYN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,765,400
Market Cap $1.55B
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.